XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual — Quarterly Financial Data (NASDAQ:XOMAP) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

ニュース

XOMA Royalty’s Preferreds Still Offer Compelling Income Despite Call Risk (NASDAQ:XOMA)

XOMA stock price target lowered to $97 by H.C. Wainwright

Leerink Partners、RZ358治験失敗によりXOMA株価目標を引き下げ

Leerink Partners lowers XOMA stock price target on RZ358 trial failure

ルシッド・キャピタル・マーケッツ、XOMAに「買い」の評価で新規カバレッジを開始

XOMAロイヤリティ社、Mural Oncologyを1株あたり2.035ドルで買収へ

Leerink Partnersがロイヤリティ見通しに基づきXOMA株価目標を58ドルに引き上げ

Leerink Partners raises XOMA stock price target to $58 on royalty outlook

XOMA Royaltyが優先株式シリーズBの指定に関する修正を提出

XOMA Royalty files correction to Series B preferred stock designation

I’m Staying Neutral On XOMA After The LAVA And HilleVax Deals (NASDAQ:XOMA)

Collect Up To 11.5% From The Healthcare Sector